oxazolidin-2-one has been researched along with Extensively Drug-Resistant Tuberculosis in 46 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (17.39) | 29.6817 |
2010's | 37 (80.43) | 24.3611 |
2020's | 1 (2.17) | 2.80 |
Authors | Studies |
---|---|
Deng, G; Fu, L; Wang, Y; Yang, M; Zhan, S; Zhang, P | 1 |
Ahmed, I; Hasan, R; Inayat, R; Jabeen, K | 1 |
Centis, R; D'Ambrosio, L; Migliori, GB; Sotgiu, G; Spanevello, A | 1 |
Chuchottaworn, C; Roongruangpitayakul, C | 1 |
Brito, M; Correia, P; Rodrigues, M; Villar, M | 1 |
Balasubramanian, V; Hoffner, S; Perskvist, N; Rodrigues, C; Sambandamurthy, VK; Werngren, J; Wijkander, M | 1 |
Andersson, J; Axelsson-Robertson, R; Keshavjee, S; Lutckii, A; Maeurer, M; Master, I; Parida, SK; Rao, MV; Singh, N; Zumla, A | 1 |
Gao, M; Huang, H; Pang, Y; Wang, Y; Yu, X; Zhang, L; Zhao, Y | 1 |
Chaiprasert, A; Charoensook, S; Leechawengwongs, M; Makhao, N; Prammananan, T; Sirirudeeporn, P; Srimuang, S; Theankeaw, O; Tingtoy, N; Tomnongdee, N | 1 |
Chang, KC; Heyckendorf, J; Lange, C; Olaru, ID; von Groote-Bidlingmaier, F; Yew, WW | 1 |
Barry, CE; Chen, RY; Cho, SN; Coleman, MT; Dartois, V; Dodd, LE; Flynn, JL; Janssen, C; Kim, Y; Klein, E; Lee, M; Lin, PL; Maiello, P; Marriner, G; Scanga, C; Via, LE; Wang, J | 1 |
Bauer, TT; Bettermann, G; Bös, L; Mauch, H; Otto-Knapp, R; Rüssmann, H; Schönfeld, N; Weiss, T | 1 |
Castiglia, P; Centis, R; D'Ambrosio, L; Migliori, GB; Sotgiu, G | 1 |
Barry, CE; Cho, SN; Jeong, I; Kim, Y; Lee, M; Song, T | 1 |
Alsleben, N; Donald, PR; Garcia-Prats, AJ; Hesseling, AC; Schaaf, HS; Willemse, M | 1 |
Benson, CA; Maartens, G | 1 |
Berry, C; du Cros, P; Phillips, PP; Seddon, JA; Yates, TA | 1 |
Condos, R; Hadgiangelis, N; Harkin, T; Jacquette, G; Leibert, E; Rom, WN | 1 |
Cho, SN; Koh, WJ; Kwon, OJ; Nam, HS; Shim, TS | 1 |
Centis, R; Eker, B; Hoffmann, H; Kirsten, D; Lange, C; Migliori, GB; Muetterlein, R; Ortmann, J; Ruesch-Gerdes, S; Schaberg, T; Sotgiu, G | 1 |
Aggarwal, D; Janmeja, AK; Mohapatra, PR | 1 |
Donald, PR; Schaaf, HS; Willemse, M | 1 |
Centis, R; Eker, B; Guenther, G; Lange, C; Matteelli, A; Migliori, GB; Richardson, MD; Sotgiu, G; Spanevello, A | 1 |
Chang, KC; Chau, CH; Yew, WW | 1 |
Koh, WJ; Shim, TS | 1 |
Alffenaar, JW; Filguera, P; Harmelink, IM; Kosterink, JG; Molenaar, E; Uges, DR; van Altena, R; van der Werf, TS; van Soolingen, D; Wessels, AM | 1 |
Dauby, N; Mouchet, F; Muylle, I; Payen, MC; Sergysels, R | 1 |
Brito, MJ; Ferreira, G; Gouveia, C; Kjöllerström, P; Varandas, L | 1 |
Freeman, JT; Goh, TL; Jones, KL; Towns, CR; Wong, CS | 1 |
Barbedo, J; Centis, R; D'Ambrosio, L; Diogo, N; Fernandes, L; Lange, C; Migliori, GB; Raymundo, E; Sotgiu, G; Villar, M | 1 |
Bali, RK; Behera, D; Caminero, JA; Gupta, S; Jaiswal, A; Singla, N; Singla, R | 1 |
Gu, J; Hao, XH; Liu, YD; Sun, H; Tangg, SJ; Xiao, HP; Yao, L; Zhang, Q; Zheng, LH | 1 |
Abbate, E; Ambroggi, M; Cufré, M; García, A; Gonzalez Montaner, P; Natiello, M; Ritacco, V; van Soolingen, D; Vescovo, M | 1 |
Campbell, S; Jakubiec, W; Ladutko, L; Miller, PF; Mitton-Fry, M; Paige, D; Silvia, A; Wallis, RS | 1 |
Cox, H; Ford, N | 1 |
Centis, R; D'Ambrosio, L; De Lorenzo, S; Migliori, GB; Sotgiu, G | 1 |
Barry, CE; Cai, Y; Carroll, MW; Choi, H; Goldfeder, LC; Hwang, S; Jeon, HS; Jin, B; Lebron, J; Lee, M; Min, S; Park, H; Park, Y; Song, T; Via, LE | 1 |
Alffenaar, JW; Anger, HA; Caminero, JA; Castiglia, P; Centis, R; D'Ambrosio, L; De Lorenzo, S; Ferrara, G; Koh, WJ; Migliori, GB; Schecter, GF; Shim, TS; Singla, R; Skrahina, A; Sotgiu, G; Spanevello, A; Udwadia, ZF; Villar, M; Zampogna, E; Zellweger, JP; Zumla, A | 1 |
Alffenaar, JW; Bolhuis, MS; Pranger, AD | 1 |
Dong, M; He, J; Jiang, Y; Lei, H; Meng, X; Tong, A; Wang, D; Yang, C; Zhu, L | 1 |
Alffenaar, JW; Bolhuis, MS; Centis, R; D'Ambrosio, L; De Lorenzo, S; Migliori, GB; Piana, A; Sotgiu, G; Spanevello, A; Tiberi, S; van Altena, R; Viggiani, P | 1 |
Hallbauer, UM; Hesseling, AC; Rose, PC; Schaaf, HS; Seddon, JA | 1 |
Barry, CE; Carroll, MW; Chen, RY; Cho, SN; Choi, H; Dartois, V; Follmann, D; Goldfeder, LC; Jeon, HS; Jeong, I; Jin, B; Joh, JS; Kang, E; Kim, CT; Kim, H; Kwak, H; Lee, D; Lee, J; Lee, JK; Lee, M; Min, S; Olivier, KN; Park, H; Park, SK; Shaw, PA; Song, SD; Song, T; Via, LE | 1 |
Jaramillo, E; Raviglione, M; Weyer, K | 1 |
Agarwal, R; Behera, D; Dhooria, S | 1 |
Cattaneo, D; Cordier, L; Orlando, G | 1 |
4 review(s) available for oxazolidin-2-one and Extensively Drug-Resistant Tuberculosis
Article | Year |
---|---|
Totally drug-resistant tuberculosis and adjunct therapies.
Topics: Drug Resistance, Bacterial; Extensively Drug-Resistant Tuberculosis; Genotype; Global Health; Host-Pathogen Interactions; Humans; Mutation; Mycobacterium tuberculosis; Nitroimidazoles; Oxazolidinones | 2015 |
Novel drugs against tuberculosis: a clinician's perspective.
Topics: Adamantane; Antitubercular Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Diarylquinolines; Drug Therapy, Combination; Ethylenediamines; Extensively Drug-Resistant Tuberculosis; Female; Follow-Up Studies; Humans; Male; Nitroimidazoles; Oxazoles; Oxazolidinones; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2015 |
Linezolid for the treatment of complicated drug-resistant tuberculosis: a systematic review and meta-analysis.
Topics: Acetamides; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Extensively Drug-Resistant Tuberculosis; Humans; Linezolid; Oxazolidinones; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2012 |
Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis.
Topics: Acetamides; Adolescent; Adult; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Female; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Patient Safety; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2012 |
4 trial(s) available for oxazolidin-2-one and Extensively Drug-Resistant Tuberculosis
Article | Year |
---|---|
Comparison of the pharmacokinetics of two dosage regimens of linezolid in multidrug-resistant and extensively drug-resistant tuberculosis patients.
Topics: Acetamides; Adult; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Female; Humans; Linezolid; Male; Oxazolidinones; Tuberculosis, Multidrug-Resistant | 2010 |
Linezolid: an effective, safe and cheap drug for patients failing multidrug-resistant tuberculosis treatment in India.
Topics: Acetamides; Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; Drug Costs; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Female; Fluoroquinolones; Humans; India; Linezolid; Male; Middle Aged; Oxazolidinones; Prospective Studies; Treatment Outcome; Young Adult | 2012 |
Rhabdomyolysis in a patient treated with linezolid for extensively drug-resistant tuberculosis.
Topics: Acetamides; Adult; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Humans; Linezolid; Male; Oxazolidinones; Rhabdomyolysis | 2012 |
Linezolid for treatment of chronic extensively drug-resistant tuberculosis.
Topics: Acetamides; Adult; Antitubercular Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Female; Humans; Kaplan-Meier Estimate; Linezolid; Male; Middle Aged; Mycobacterium tuberculosis; Oxazolidinones; Sputum; Young Adult | 2012 |
38 other study(ies) available for oxazolidin-2-one and Extensively Drug-Resistant Tuberculosis
Article | Year |
---|---|
Prospects of contezolid (MRX-I) against multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis.
Topics: Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Humans; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones; Pyridones; Tuberculosis, Multidrug-Resistant | 2022 |
Susceptibility testing of extensively drug-resistant and pre-extensively drug-resistant Mycobacterium tuberculosis against levofloxacin, linezolid, and amoxicillin-clavulanate.
Topics: Acetamides; Amoxicillin-Potassium Clavulanate Combination; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Humans; Levofloxacin; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Oxazolidinones; Pakistan; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2013 |
Linezolid to treat extensively drug-resistant TB: retrospective data are confirmed by experimental evidence.
Topics: Acetamides; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Female; Humans; Male; Oxazolidinones; Tuberculosis, Multidrug-Resistant | 2013 |
Outcomes of MDR/XDR-TB patients treated with linezolid: experience in Thailand.
Topics: Acetamides; Adult; Anti-Infective Agents; Antitubercular Agents; Capreomycin; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Female; Humans; Linezolid; Male; Middle Aged; Off-Label Use; Oxazolidinones; Retrospective Studies; Thailand; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2013 |
Treatment of multidrug-resistant and extensively drug-resistant tuberculosis in adolescent patients.
Topics: Acetamides; Adolescent; Antitubercular Agents; Child; Extensively Drug-Resistant Tuberculosis; Female; Humans; Linezolid; Male; Mycobacterium tuberculosis; Oxazolidinones; Tuberculosis, Multidrug-Resistant | 2014 |
In vitro activity of AZD5847 against geographically diverse clinical isolates of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones; Tuberculosis, Pulmonary | 2014 |
Linezolid in the treatment of extensively drug-resistant tuberculosis.
Topics: Acetamides; Adolescent; Adult; Aged; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Female; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Oxazolidinones; Retrospective Studies; Treatment Outcome; Young Adult | 2014 |
Second-line drug susceptibilities of multidrug-resistant tuberculosis strains isolated in Thailand: an update.
Topics: Acetamides; Aminoglycosides; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones; Thailand; Tuberculosis, Multidrug-Resistant | 2014 |
PET/CT imaging reveals a therapeutic response to oxazolidinones in macaques and humans with tuberculosis.
Topics: Acetamides; Algorithms; Animals; Anti-Bacterial Agents; Extensively Drug-Resistant Tuberculosis; Fluorodeoxyglucose F18; Humans; Linezolid; Lymph Nodes; Macaca; Multimodal Imaging; Oxazolidinones; Positron-Emission Tomography; Stem Cells; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Low minimal inhibitory concentrations of linezolid against multidrug-resistant tuberculosis strains.
Topics: Acetamides; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Female; Humans; Male; Oxazolidinones; Tuberculosis, Multidrug-Resistant | 2015 |
Low minimal inhibitory concentrations of linezolid against multidrug-resistant tuberculosis strains.
Topics: Acetamides; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Female; Humans; Male; Oxazolidinones; Tuberculosis, Multidrug-Resistant | 2015 |
Linezolid for XDR-TB--Final Study Outcomes.
Topics: Acetamides; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Humans; Linezolid; Mycobacterium tuberculosis; Oxazolidinones; Protein Synthesis Inhibitors; Sputum; Treatment Outcome | 2015 |
Successful Treatment of a Child With Extensively Drug-Resistant Tuberculous Meningitis.
Topics: Anti-Inflammatory Agents; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Child, Preschool; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Female; Humans; Hypothyroidism; Isoxazoles; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones; Prednisolone; Treatment Outcome; Tuberculosis, Meningeal | 2015 |
Linezolid for Treating Tuberculosis: A Delicate Balancing Act.
Topics: Acetamides; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Humans; Linezolid; Mycobacterium tuberculosis; Oxazolidinones; Treatment Outcome; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2015 |
Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in China.
Topics: Antitubercular Agents; China; Extensively Drug-Resistant Tuberculosis; Humans; Linezolid; Oxazolidinones; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2016 |
Case series report of a linezolid-containing regimen for extensively drug-resistant tuberculosis.
Topics: Acetamides; Adult; Anti-Infective Agents; Child; Dose-Response Relationship, Drug; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Female; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Tuberculosis, Multidrug-Resistant | 2008 |
Daily half-dose linezolid for the treatment of intractable multidrug-resistant tuberculosis.
Topics: Acetamides; Adult; Anti-Infective Agents; Culture Media; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Female; Humans; Korea; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Oxazolidinones; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult | 2009 |
Multidrug- and extensively drug-resistant tuberculosis, Germany.
Topics: Acetamides; Adult; Antitubercular Agents; Cohort Studies; Drug Resistance, Multiple, Bacterial; Emigrants and Immigrants; Extensively Drug-Resistant Tuberculosis; Female; Germany; Humans; Linezolid; Male; Mycobacterium tuberculosis; Oxazolidinones; Retrospective Studies; Risk Factors; Sentinel Surveillance; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2008 |
Treatment of extensively drug-resistant tuberculosis.
Topics: Acetamides; Anti-Infective Agents; Antitubercular Agents; Aza Compounds; Dose-Response Relationship, Drug; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Linezolid; Moxifloxacin; Oxazolidinones; Quinolines | 2009 |
Long-term linezolid treatment in a young child with extensively drug-resistant tuberculosis.
Topics: Acetamides; Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Female; Humans; Infant; Linezolid; Oxazolidinones; Tuberculosis, Pulmonary | 2009 |
Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
Topics: Acetamides; Anti-Bacterial Agents; Extensively Drug-Resistant Tuberculosis; Humans; Linezolid; Oxazolidinones; Tuberculosis, Multidrug-Resistant | 2009 |
Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
Topics: Acetamides; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Humans; Linezolid; Oxazolidinones; Tuberculosis, Multidrug-Resistant | 2009 |
Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis--authors' response.
Topics: Acetamides; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Humans; Linezolid; Oxazolidinones; Tuberculosis, Multidrug-Resistant | 2009 |
Meropenem/clavulanate and linezolid treatment for extensively drug-resistant tuberculosis.
Topics: Acetamides; Adolescent; Antitubercular Agents; Clavulanic Acid; Extensively Drug-Resistant Tuberculosis; Female; Humans; Linezolid; Meropenem; Oxazolidinones; Thienamycins; Treatment Outcome | 2011 |
Linezolid in the treatment of multidrug-resistant/extensively drug-resistant tuberculosis in paediatric patients: experience of a paediatric infectious diseases unit.
Topics: Acetamides; Adolescent; Antitubercular Agents; Child; Child, Preschool; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Female; Humans; Linezolid; Male; Oxazolidinones; Treatment Outcome | 2011 |
Extensively drug-resistant tuberculosis: New Zealand's first case and the challenges of management in a low-prevalence country.
Topics: Acetamides; Adult; Aminosalicylic Acid; Antitubercular Agents; Aza Compounds; Cycloserine; Emigrants and Immigrants; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Imipenem; Linezolid; Lymph Nodes; Male; Moxifloxacin; Myanmar; New Zealand; Oxazolidinones; Quinolines; Radiography | 2011 |
Linezolid safety, tolerability and efficacy to treat multidrug- and extensively drug-resistant tuberculosis.
Topics: Acetamides; Adult; Amikacin; Antitubercular Agents; Capreomycin; Drug-Related Side Effects and Adverse Reactions; Extensively Drug-Resistant Tuberculosis; Female; Fluoroquinolones; Humans; Infectious Disease Medicine; Isoniazid; Kanamycin; Linezolid; Male; Middle Aged; Oxazolidinones; Rifampin | 2011 |
Efficacy and safety of linezolid in the treatment of extensively drug-resistant tuberculosis.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Drug Monitoring; Extensively Drug-Resistant Tuberculosis; Female; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Oxazolidinones; Radiography, Thoracic; Sputum; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Successful alternative treatment of extensively drug-resistant tuberculosis in Argentina with a combination of linezolid, moxifloxacin and thioridazine.
Topics: Acetamides; Adult; Antitubercular Agents; Argentina; Aza Compounds; Compassionate Use Trials; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Female; Fluoroquinolones; Humans; Linezolid; Male; Middle Aged; Moxifloxacin; Mycobacterium tuberculosis; Oxazolidinones; Quinolines; Retrospective Studies; Thioridazine; Treatment Outcome; Tuberculosis, Pulmonary | 2012 |
Rapid evaluation in whole blood culture of regimens for XDR-TB containing PNU-100480 (sutezolid), TMC207, PA-824, SQ109, and pyrazinamide.
Topics: Adamantane; Antitubercular Agents; Diarylquinolines; Drug Monitoring; Drug Therapy, Combination; Ethylenediamines; Extensively Drug-Resistant Tuberculosis; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitroimidazoles; Oxazolidinones; Pyrazinamide; Quinolines; Reproducibility of Results; Time Factors | 2012 |
On linezolid efficacy and tolerability.
Topics: Acetamides; Adult; Antitubercular Agents; Cohort Studies; Extensively Drug-Resistant Tuberculosis; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Treatment Outcome | 2012 |
Linezolid: safety and efficacy monitoring.
Topics: Acetamides; Drug Costs; Extensively Drug-Resistant Tuberculosis; Female; Humans; Male; Oxazolidinones | 2012 |
In vitro activity of linezolid against clinical isolates of Mycobacterium tuberculosis, including multidrug-resistant and extensively drug-resistant strains from Beijing, China.
Topics: Acetamides; Antitubercular Agents; China; Extensively Drug-Resistant Tuberculosis; Humans; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones; Tuberculosis, Multidrug-Resistant | 2012 |
Efficacy and safety of meropenem-clavulanate added to linezolid-containing regimens in the treatment of MDR-/XDR-TB.
Topics: Acetamides; Adult; Antitubercular Agents; Case-Control Studies; Clavulanic Acid; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Female; Humans; Linezolid; Male; Meropenem; Middle Aged; Oxazolidinones; Thienamycins; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2013 |
Linezolid-containing regimens for the treatment of drug-resistant tuberculosis in South African children.
Topics: Acetamides; Adolescent; Age Factors; Anti-HIV Agents; Antitubercular Agents; Child; Child, Preschool; Coinfection; Cost Savings; Drug Costs; Drug Interactions; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Female; HIV Infections; Humans; Infant; Linezolid; Male; Mycobacterium tuberculosis; Oxazolidinones; Retrospective Studies; South Africa; Sputum; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2012 |
Linezolid for extensively drug-resistant tuberculosis.
Topics: Acetamides; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Female; Humans; Male; Oxazolidinones | 2013 |
Linezolid for extensively drug-resistant tuberculosis.
Topics: Acetamides; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Female; Humans; Male; Oxazolidinones | 2013 |
Linezolid for extensively drug-resistant tuberculosis.
Topics: Acetamides; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Female; Humans; Male; Oxazolidinones | 2013 |